Rapid Therapeutic Science Laboratories Inc. (RTSL)
Market Closed
11 Aug, 20:00
OTC PINK OTC PINK Primary $
0. 00
0
0%
$
883 Market Cap
0.5 P/E Ratio
- Div Yield
9,500 Volume
0 Eps
$ 0
Previous Close Want to track RTSL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Rapid Therapeutic Science Laboratories Inc. (RTSL) Statistics
Valuation metrics
Market Cap 883
Enterprise value 3.45M
Trailing P/E (ttm) -0.01
Forward P/E -
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) -0
Enterprise Value/Revenue -
Enterprise Value/EBITDA -58.19
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.36K
Average volume (90 days) 971
Price summary
52-Week low 0
52-Week high 0.01
Beta -
50-Day moving average 0
200-Day moving average 0
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:25
Last split Date 31 Mar 2022
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.19%
Return on equity 0.06%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.01
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) -
Total debt (mrq) -
Total Debt/Equity (mrq) -1.12
Current ratio (mrq) 0.04%
Book value per share (mrq) -0.16
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
